ClinicalTrials.gov
ClinicalTrials.gov Menu

Association Between Levels of D-Dimer, Fibrinogen and PAI-1 in Elderly Patients With Infection and Occurrence of Cardio- and Cerebro-vascular Disease After Discharge

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00512603
Recruitment Status : Completed
First Posted : August 7, 2007
Last Update Posted : January 16, 2013
Sponsor:
Information provided by (Responsible Party):
Asher Winder, Wolfson Medical Center

Brief Summary:
The association between the levels of d-dimer, fibrinogen and PAI-1 in plasma of elderly patients admitted to internal medicine departments because of infection and the occurrence of cardio- and cerebro-vascular disease after discharge

Condition or disease
Infection Acute Coronary Syndrome Cerebrovascular Disease

Study Type : Observational
Actual Enrollment : 52 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2007
Actual Primary Completion Date : January 2008
Actual Study Completion Date : July 2008

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. thrombosis [ Time Frame: 24 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Elderly patients hospitalized due to infections
Criteria

Inclusion Criteria:

  • Acute infection

Exclusion Criteria:

  • Anticoagulant therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00512603


Sponsors and Collaborators
Wolfson Medical Center
Investigators
Principal Investigator: Asher Winder, MD Wolfson Medical Center

Responsible Party: Asher Winder, Senior Physician, Institute of Hematology, Wolfson Medical Center, Holon, Israel. Responsible of Thrombosis & Hemostasis clinic, Wolfson Medical Center
ClinicalTrials.gov Identifier: NCT00512603     History of Changes
Other Study ID Numbers: DD-CVD-1
First Posted: August 7, 2007    Key Record Dates
Last Update Posted: January 16, 2013
Last Verified: May 2007

Keywords provided by Asher Winder, Wolfson Medical Center:
cerebro vascular event

Additional relevant MeSH terms:
Infection
Acute Coronary Syndrome
Cerebrovascular Disorders
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases